Literature DB >> 17699130

Diuretics in obstructive sleep apnea with diastolic heart failure.

Caterina B Bucca1, Luisa Brussino, Alberto Battisti, Roberto Mutani, Giovanni Rolla, Lucia Mangiardi, Alessandro Cicolin.   

Abstract

BACKGROUND: Upper airway edema might contribute to pharyngeal collapsibility and account for the high prevalence of obstructive sleep apnea (OSA) in patients with heart disease. The aim of this study was to evaluate if intensive unloading with diuretics improves sleep-disordered breathing and increases pharyngeal caliber in patients with severe OSA and diastolic heart failure.
METHODS: Fifteen patients with severe OSA, hypertension, and diastolic heart failure were hospitalized to receive IV furosemide, 20 mg, and spironolactone, 100 mg, bid for 3 days. Polysomnography was performed for assessment of apnea-hypopnea index (AHI), acoustic pharyngometry was performed for assessment of the oropharyngeal junction (OPJ) area, and forced midinspiratory flow (FIF(50)), forced midexpiratory flow (FEF(50))/FIF(50) percentage, and exhaled nitric oxide (FeNO) were measured before and after diuretic treatment.
RESULTS: Diuretic treatment produced a significant decrease in body weight, BP, and AHI (from 74.89 +/- 6.95 to 57.17 +/- 5.40/h, p < 0.001), associated with an improvement in OPJ area (from 1.33 +/- 0.10 to 1.78 +/- 0.16 cm(2), p = 0.007), FIF(50) (from 3.16 +/- 0.4 to 3.94 +/- 0.4 L/s, p = 0.006), and FEF(50)/FIF(50) percentage (from 117.9 +/- 11.8 to 93.15 +/- 10.1%, p = 0.002). Weight loss was significantly related to the decrease of AHI (R = 0.602; p = 0.018), to the increase of FIF(50) (R = 0.68; p = 0.005), and to the decrease of FEF(50)/FIF(50) (R = 0.635; p = 0.011).
CONCLUSIONS: These findings suggest that pharyngeal edema contributes to sleep-disordered breathing in obese patients with severe OSA, hypertension, and diastolic heart failure. Upper airway edema may contribute to the frequent occurrence of OSA in patients with heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699130     DOI: 10.1378/chest.07-0311

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  52 in total

Review 1.  Sleep in congestive heart failure.

Authors:  Bhavneesh Sharma; Robert Owens; Atul Malhotra
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Sleep and hypertension.

Authors:  David A Calhoun; Susan M Harding
Journal:  Chest       Date:  2010-08       Impact factor: 9.410

Review 3.  Obstructive sleep apnea and hypertension.

Authors:  David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

4.  Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.

Authors:  Carolina C Gonzaga; Krishna K Gaddam; Mustafa I Ahmed; Eduardo Pimenta; S Justin Thomas; Susan M Harding; Suzanne Oparil; Stacey S Cofield; David A Calhoun
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

Review 5.  Effect of Antihypertensive Medications on the Severity of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Kiran Khurshid; Jonathan Yabes; Patricia M Weiss; Sushma Dharia; Lee Brown; Mark Unruh; Manisha Jhamb
Journal:  J Clin Sleep Med       Date:  2016-08-15       Impact factor: 4.062

6.  Evaluation of the association between sleep apnea and polyunsaturated fatty acids profiles in patients after percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Katsumi Saito; Toshiaki Oka; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

Review 7.  Future of Sleep-Disordered Breathing Therapy Using a Mechanistic Approach.

Authors:  Rachel Jen; Michael A Grandner; Atul Malhotra
Journal:  Can J Cardiol       Date:  2015-02-14       Impact factor: 5.223

Review 8.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

Review 9.  Role of Mineralocorticoid Receptors in Obstructive Sleep Apnea and Metabolic Syndrome.

Authors:  Badhma Valaiyapathi; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

10.  Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.

Authors:  K Gaddam; E Pimenta; S J Thomas; S S Cofield; S Oparil; S M Harding; D A Calhoun
Journal:  J Hum Hypertens       Date:  2009-12-17       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.